Key Details
Price
$29.98Annual ROE
-199.89%Beta
1.83Events Calendar
Next earnings date:
May 9, 2025Recent quarterly earnings:
Mar 3, 2025Recent annual earnings:
Mar 3, 2025Next ex-dividend date:
N/ARecent ex-dividend date:
N/ANext split:
N/ARecent split:
N/AAnalyst ratings
Recent major analysts updates
Mar 5, 25 JP Morgan
OverweightMar 4, 25 RBC Capital
OutperformMar 4, 25 HC Wainwright & Co.
BuyFeb 11, 25 Deutsche Bank
BuyDec 17, 24 HC Wainwright & Co.
BuyDec 17, 24 Cantor Fitzgerald
OverweightDec 4, 24 RBC Capital
OutperformNov 26, 24 HC Wainwright & Co.
BuyNov 25, 24 RBC Capital
OutperformNov 14, 24 HC Wainwright & Co.
BuyMarket Data
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Price
Market cap
Technical
Dividend
Biohaven Pharmaceutical Holding doesn't have historical dividend data
Profitability
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Revenue
Profit
EPS
ROA & ROE
EBIT & EBITDA
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Leverage
Risk & Stability
Balance Sheet
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Assets
Equity
Liabilities
Debt
Expenses
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cash Flow
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cashflow Activities
Free CashFlow
CAPEX
Institutional Ownership
FAQ
- What is the ticker symbol for Biohaven Pharmaceutical Holding?
- Does Biohaven Pharmaceutical Holding pay dividends?
- What sector is Biohaven Pharmaceutical Holding in?
- What industry is Biohaven Pharmaceutical Holding in?
- What country is Biohaven Pharmaceutical Holding based in?
- When did Biohaven Pharmaceutical Holding go public?
- Is Biohaven Pharmaceutical Holding in the S&P 500?
- Is Biohaven Pharmaceutical Holding in the NASDAQ 100?
- Is Biohaven Pharmaceutical Holding in the Dow Jones?
- When was Biohaven Pharmaceutical Holding's last earnings report?
- When does Biohaven Pharmaceutical Holding report earnings?
- Should I buy Biohaven Pharmaceutical Holding stock now?
What is the ticker symbol for Biohaven Pharmaceutical Holding?
The ticker symbol for Biohaven Pharmaceutical Holding is NYSE:BHVN
Does Biohaven Pharmaceutical Holding pay dividends?
No, Biohaven Pharmaceutical Holding does not pay dividends
What sector is Biohaven Pharmaceutical Holding in?
Biohaven Pharmaceutical Holding is in the Healthcare sector
What industry is Biohaven Pharmaceutical Holding in?
Biohaven Pharmaceutical Holding is in the Biotechnology industry
What country is Biohaven Pharmaceutical Holding based in?
Biohaven Pharmaceutical Holding is headquartered in United States
When did Biohaven Pharmaceutical Holding go public?
Biohaven Pharmaceutical Holding's initial public offering (IPO) was on September 23, 2022
Is Biohaven Pharmaceutical Holding in the S&P 500?
No, Biohaven Pharmaceutical Holding is not included in the S&P 500 index
Is Biohaven Pharmaceutical Holding in the NASDAQ 100?
No, Biohaven Pharmaceutical Holding is not included in the NASDAQ 100 index
Is Biohaven Pharmaceutical Holding in the Dow Jones?
No, Biohaven Pharmaceutical Holding is not included in the Dow Jones index
When was Biohaven Pharmaceutical Holding's last earnings report?
Biohaven Pharmaceutical Holding's most recent earnings report was on Mar 3, 2025
When does Biohaven Pharmaceutical Holding report earnings?
The next expected earnings date for Biohaven Pharmaceutical Holding is May 9, 2025
Should I buy Biohaven Pharmaceutical Holding stock now?
As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions